International Brand Name:
1.25 MG/2.5 mg/5 mg/10 mg
In treatment of:
Management of Hyper Tension(HTN)
8.Swelling of lips, mouth, nose, and larynx
9.Fetopathic in later half of pregnancy
17.Acute renal failure is precipitated in renal artery stenosis
1.Hypersensitivity to the drug
2.Renal artery stenosis
4.Coarctation of aorta
3.Use cautiously in patient at high risk of cardiogenic shock, severe heart failure etc
4.Anaesthesia and surgery
Antacids: May decrease bioavailability of ramipril.
Phenothiazines: Pharmacologic effects enhanced by phenothiazines.
Allupurinol: Higher risk of hypersensitivity reactions.
Digoxin: Increases plasma digoxin levels.
Potassium preparations & Potassium sparing diuretics: Hyperkalaemia and increased risk of renal failure.
Lithium: Toxicity due to increased serum concentration of lithium.
Starts with 1.25mg once daily. Increases the dose to 2.5 to 5mg once daily; depending on patient`s response.
Maximum dose: 10mg once daily.
In CHF patients starts the dosage with 1.5mg once daily dosage and gradually increases at 2 to3 weeks` intervals to usual dosage.